An association analysis of the rs1572931 polymorphism of the RAB7L1 gene in Parkinson's disease, amyotrophic lateral sclerosis and multiple system atrophy in China

European Journal of Neurology

Volumn 21, Issue 10, 2014, Pages 1337-1343

  Guo, X Y ^a   Chen, Y P ^a   Song, W ^a   Zhao, B ^a   Cao, B ^a   Wei, Q Q ^a   Ou, R W ^a   Yang, Y ^a   Yuan, L X ^b   Shang, H F ^a  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

Author keywords

RAB7L1; Amyotrophic lateral sclerosis; Multiple system atrophy; Parkinson's disease; Polymorphism; Rs1572931

Indexed keywords

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ANXIETY; ARTICLE; CHINA; CHINESE; COGNITIVE DEFECT; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; FEMALE; GENE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PARKINSON DISEASE; PRIORITY JOURNAL; RAB7L1 GENE; SHY DRAGER SYNDROME; SINGLE NUCLEOTIDE POLYMORPHISM; GENETIC POLYMORPHISM; GENETICS; MULTIPLE SYSTEM ATROPHY; STATISTICS AND NUMERICAL DATA;

RAB PROTEIN; RAB29 PROTEIN, HUMAN;

ADULT; AGE OF ONSET; AMYOTROPHIC LATERAL SCLEROSIS; CHINA; FEMALE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; MULTIPLE SYSTEM ATROPHY; PARKINSON DISEASE; POLYMORPHISM, GENETIC; RAB1 GTP-BINDING PROTEINS;

EID: 84908671264     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/ene.12490     Document Type: Article

References (34)

1. Fahn S. Description of Parkinson's disease as a clinical syndrome. Ann N Y Acad Sci 2003; 991: 1-14.
2. Lesage S, Brice A. Role of mendelian genes in 'sporadic' Parkinson's disease. Parkinsonism Relat Disord 2012; 18(Suppl. 1): S66-S70.
3. Wider C, Ross OA, Wszolek ZK. Genetics of Parkinson disease and essential tremor. Curr Opin Neurol 2010; 23: 388-393.
4. MacLeod DA, Rhinn H, Kuwahara T, et al. RAB7L1 interacts with LRRK2 to modify intraneuronal protein sorting and Parkinson's disease risk. Neuron 2013; 77: 425-439.
5. Tucci A, Nalls MA, Houlden H, et al. Genetic variability at the PARK16 locus. Eur J Hum Genet 2010; 18: 1356-1359.
6. Yan Y, Tian J, Mo X, et al. Genetic variants in the RAB7L1 and SLC41A1 genes of the PARK16 locus in Chinese Parkinson's disease patients. Int J Neurosci 2011; 121: 632-636.
7. Gan-Or Z, Bar-Shira A, Dahary D, et al. Association of sequence alterations in the putative promoter of RAB7L1 with a reduced Parkinson disease risk. Arch Neurol 2012; 69: 105-110.
8. Majoor-Krakauer D, Ottman R, Johnson WG, Rowland LP. Familial aggregation of amyotrophic lateral sclerosis, dementia, and Parkinson's disease: evidence of shared genetic susceptibility. Neurology 1994; 44: 1872-1877.
9. Gouras GK. Convergence of synapses, endosomes, and prions in the biology of neurodegenerative diseases. Int J Cell Biol 2013; 2013: 141083.
10. Kokubo Y, Taniguchi A, Hasegawa M, et al. alpha-Synuclein pathology in the amyotrophic lateral sclerosis/parkinsonism dementia complex in the Kii Peninsula, Japan. J Neuropathol Exp Neurol 2012; 71: 625-630.
11. Yamada T, Itoh K, Matsuo K, et al. Concomitant alpha-synuclein pathology in an autopsy case of amyotrophic lateral sclerosis presenting with orthostatic hypotension and cardiac arrests. Neuropathology 2014; 34: 164-169.
12. Nakashima-Yasuda H, Uryu K, Robinson J, et al. Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases. Acta Neuropathol 2007; 114: 221-229.
13. Quadri M, Cossu G, Saddi V, et al. Broadening the phenotype of TARDBP mutations: the TARDBP Ala382Thr mutation and Parkinson's disease in Sardinia. Neurogenetics 2011; 12: 203-209.
14. Whittle AJ, Ross OA, Naini A, et al. Pathogenic Lrrk2 substitutions and amyotrophic lateral sclerosis. J Neural Transm 2007; 114: 327-329.
15. Ross OA, Rutherford NJ, Baker M, et al. Ataxin-2 repeat-length variation and neurodegeneration. Hum Mol Genet 2011; 20: 3207-3212.
16. Nuytemans K, Bademci G, Kohli MM, et al. C9ORF72 intermediate repeat copies are a significant risk factor for Parkinson disease. Ann Hum Genet 2013; 77: 351-363.
17. Ahmed Z, Asi YT, Sailer A, et al. The neuropathology, pathophysiology and genetics of multiple system atrophy. Neuropathol Appl Neurobiol 2012; 38: 4-24.
18. Turner MR, Bowser R, Bruijn L, et al. Mechanisms, models and biomarkers in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener 2013; 14(Suppl. 1): 19-32.
19. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992; 55: 181-184.
20. Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000; 1: 293-299.
21. Gilman S, Wenning GK, Low PA, et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology 2008; 71: 670-676.
22. Schrag A, Schott JM. Epidemiological, clinical, and genetic characteristics of early-onset parkinsonism. Lancet Neurol 2006; 5: 355-363.
23. Butterfield PG, Valanis BG, Spencer PS, Lindeman CA, Nutt JG. Environmental antecedents of young-onset Parkinson's disease. Neurology 1993; 43: 1150-1158.
24. Butcher NJ, Kiehl TR, Hazrati LN, et al. Association between early-onset Parkinson disease and 22q11.2 deletion syndrome: identification of a novel genetic form of Parkinson disease and its clinical implications. JAMA Neurol 2013; 70: 1359-1366.
25. Eggers C, Kahraman D, Fink GR, Schmidt M, Timmermann L. Akinetic-rigid and tremor-dominant Parkinson's disease patients show different patterns of FP-CIT single photon emission computed tomography. Mov Disord 2011; 26: 416-423.
26. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol 1959; 32: 50-55.
27. Moberg PJ, Lazarus LW, Mesholam RI, et al. Comparison of the standard and structured interview guide for the Hamilton Depression Rating Scale in depressed geriatric inpatients. Am J Geriatr Psychiatry 2001; 9: 35-40.
28. Nasreddine ZS, Phillips NA, Bedirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005; 53: 695-699.
29. Shimizu F, Katagiri T, Suzuki M, et al. Cloning and chromosome assignment to 1q32 of a human cDNA (RAB7L1) encoding a small GTP-binding protein, a member of the RAS superfamily. Cytogenet Cell Genet 1997; 77: 261-263.
30. Vilarino-Guell C, Wider C, Ross OA, et al. VPS35 mutations in Parkinson disease. Am J Hum Genet 2011; 89: 162-167.
31. Soto-Ortolaza AI, Heckman MG, Labbe C, et al. GWAS risk factors in Parkinson's disease: LRRK2 coding variation and genetic interaction with PARK16. Am J Neurodegener Dis 2013; 2: 287-299.
32. Chung SJ, Jung Y, Hong M, et al. Alzheimer's disease and Parkinson's disease genome-wide association study: top hits and risk of Parkinson's disease in Korean population. Neurobiol Aging 2013; 34: 2695.e1-e7.
33. Cui HG, Tian XF, Luo XG, et al. Association of five SNPs at the PARK16 locus as a susceptibility locus with Parkinson's disease for forensic application. Fa Yi Xue Za Zhi 2013; 29: 185-189.
34. Spatola M, Wider C. Genetics of Parkinson's disease: the yield. Parkinsonism Relat Disord 2014; 20(Suppl. 1): S35-S38.